Endovascular treatment for @entity1228 with or without lower extremity XXXX : A retrospective study on mid-term in-stent patency from a single center.

@entity1150 @entity1 @entity1228
PURPOSE: The purpose of this study was to evaluate mid-term patency of iliac vein following endovascular treatment for @entity1228 ( @entity1228 ) with or without @entity1150 ( @entity1150 ). MATERIALS AND METHODS: The authors' institutional review board approved the study. Two hundred and thirty-three consecutive @entity1 with @entity1228 were treated with endovascular treatment and followed up. The therapeutic strategies and complications were recorded. Cumulative patency was assessed with Kaplan-Meier curves. Independent predictors of in-stent obstruction were calculated with the Cox regression model. RESULTS: Endovascular treatment was technically successful in 225 of the 233 @entity1 (96.6%). All of 225 @entity1 were treated with percutaneous transluminal angioplasty and stent placement. No severe procedure-related complications occurred. The cumulative 1-, 3- and 5-year primary patency rates over a median follow-up time of 34 months (range, 0.3-82 months) were 93.2%, 84.3% and 74.5%, respectively. Independent predictors for in-stent obstruction included use of multiple stents and irregular stocking wearing. The cumulative 1-, 3-, 5-year secondary patency rates were 100%, 93.3% and 92%, respectively. CONCLUSIONS: Endovascular treatment could achieve favorable mid-term patency in @entity1 with @entity1228 with or without @entity1150 .
